Clinical Genitourinary Cancer · 2017 · 40 citations · 19 references
MedicineOncologyPharmacotherapyChemotherapyMedical OncologyUrologic OncologyChemotherapy ResistanceChemotherapy Toxicity ManagementCombination ChemotherapyGenitourinary Cancer PharmacotherapyMetastatic Disease TreatmentProstate Cancer5-Alpha-reductase Inhibitor TherapyCastration-resistant Prostate Cancer TherapyChemotherapy For Prostate CancerMetastatic Castration-resistant Prostate CancerMetastatic Hormone-sensitive Prostate Cancer TherapyProstate Cancer Hormonal TherapyProstate Cancer Hormone Therapy
19
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher, Karim Fizazi, Fred Saad et al. · New England Journal of Medicine · 2012 · 4.6K citations · Full text
Medicine, Oncology, Pharmacology +14
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. de Bono, Christopher J. Logothetis, Arturo Molina et al. · New England Journal of Medicine · 2011 · 4.4K citations · Full text
Medicine, Oncology, Pharmacology +17
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
Tomasz M. Beer, Andrew J. Armstrong, Dana E. Rathkopf et al. · New England Journal of Medicine · 2014 · 3K citations · Full text
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Charles J. Ryan, Matthew R. Smith, Johann S. de Bono et al. · New England Journal of Medicine · 2012 · 2.8K citations · Full text
Medicine, Oncology, Pharmacology +17